141 related articles for article (PubMed ID: 20370650)
1. Cell death targeting therapies in B lymphoid malignancies.
Saborit-Villarroya I; Roué G; López-Guerra M; Alonso R; Xargay-Torrent S; Rosich L; Colomer D
Curr Drug Targets; 2010 Jul; 11(7):769-80. PubMed ID: 20370650
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis-based therapies for hematologic malignancies.
Reed JC; Pellecchia M
Blood; 2005 Jul; 106(2):408-18. PubMed ID: 15797997
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of apoptotic pathways in cancer.
Meiler J; Schuler M
Curr Drug Targets; 2006 Oct; 7(10):1361-9. PubMed ID: 17073598
[TBL] [Abstract][Full Text] [Related]
4. Targeting apoptosis proteins in hematological malignancies.
Droin N; Guéry L; Benikhlef N; Solary E
Cancer Lett; 2013 May; 332(2):325-34. PubMed ID: 21767908
[TBL] [Abstract][Full Text] [Related]
5. Emerging therapies for B-cell non-Hodgkin lymphoma.
Briones J
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1305-16. PubMed ID: 19761434
[TBL] [Abstract][Full Text] [Related]
6. Targeting the apoptosis pathway in hematologic malignancies.
Zaman S; Wang R; Gandhi V
Leuk Lymphoma; 2014 Sep; 55(9):1980-92. PubMed ID: 24295132
[TBL] [Abstract][Full Text] [Related]
7. Targeting apoptosis pathways in cancer therapy.
Fulda S; Debatin KM
Curr Cancer Drug Targets; 2004 Nov; 4(7):569-76. PubMed ID: 15578914
[TBL] [Abstract][Full Text] [Related]
8. Regulation of autophagy in hematological malignancies: role of reactive oxygen species.
Ishdorj G; Li L; Gibson SB
Leuk Lymphoma; 2012 Jan; 53(1):26-33. PubMed ID: 21749305
[TBL] [Abstract][Full Text] [Related]
9. The role of apoptosis in cancer development and treatment: focusing on the development and treatment of hematologic malignancies.
Zivny J; Klener P; Pytlik R; Andera L
Curr Pharm Des; 2010 Jan; 16(1):11-33. PubMed ID: 20214615
[TBL] [Abstract][Full Text] [Related]
10. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
Moretti L; Yang ES; Kim KW; Lu B
Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis signaling and BCL-2 pathways provide opportunities for novel targeted therapeutic strategies in hematologic malignances.
Wu H; Medeiros LJ; Young KH
Blood Rev; 2018 Jan; 32(1):8-28. PubMed ID: 28802908
[TBL] [Abstract][Full Text] [Related]
12. Targeting IAP (inhibitor of apoptosis) proteins for therapeutic intervention in tumors.
Vucic D
Curr Cancer Drug Targets; 2008 Mar; 8(2):110-7. PubMed ID: 18336193
[TBL] [Abstract][Full Text] [Related]
13. Emerging immunotherapy and strategies directly targeting B cells for the treatment of diffuse large B-cell lymphoma.
Witkowska M; Smolewski P
Immunotherapy; 2015; 7(1):37-46. PubMed ID: 25572478
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of apoptosis proteins as targets for anticancer therapy.
Fulda S
Expert Rev Anticancer Ther; 2007 Sep; 7(9):1255-64. PubMed ID: 17892425
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase inhibitors against malignant lymphoma.
D'Cruz OJ; Uckun FM
Expert Opin Pharmacother; 2013 Apr; 14(6):707-21. PubMed ID: 23496343
[TBL] [Abstract][Full Text] [Related]
16. TRAIL/TRAIL-R in hematologic malignancies.
Testa U
J Cell Biochem; 2010 May; 110(1):21-34. PubMed ID: 20336667
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic targeting of cell death pathways.
Mansilla S; Llovera L; Portugal J
Anticancer Agents Med Chem; 2012 Mar; 12(3):226-38. PubMed ID: 22263795
[TBL] [Abstract][Full Text] [Related]
18. Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms.
Reed JC
Nat Clin Pract Oncol; 2006 Jul; 3(7):388-98. PubMed ID: 16826219
[TBL] [Abstract][Full Text] [Related]
19. The potential and limitations of p38MAPK as a drug target for the treatment of hematological malignancies.
Gaundar SS; Bendall LJ
Curr Drug Targets; 2010 Jul; 11(7):823-33. PubMed ID: 20370645
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and diseases: regulation and clinical relevance.
Alenzi FQ
Saudi Med J; 2005 Nov; 26(11):1679-90. PubMed ID: 16311648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
